Total Payments
$12,366
2024 Payments
$1,710
Companies
64
Transactions
720
Medicare Patients
7,734
Medicare Billing
$512,198
Payment Breakdown by Category
Food & Beverage$12,143 (98.2%)
Education$222.89 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,143 | 715 | 98.2% |
| Education | $222.89 | 5 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,804 | 118 | $0 (2024) |
| ABBVIE INC. | $1,358 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $967.79 | 85 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $745.21 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $691.28 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $626.47 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $603.08 | 25 | $0 (2022) |
| PFIZER INC. | $525.47 | 21 | $0 (2024) |
| Amgen Inc. | $524.05 | 31 | $0 (2024) |
| Lilly USA, LLC | $476.07 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,710 | 81 | AstraZeneca Pharmaceuticals LP ($353.57) |
| 2023 | $1,898 | 89 | Bayer Healthcare Pharmaceuticals Inc. ($267.90) |
| 2022 | $2,412 | 133 | ABBVIE INC. ($377.95) |
| 2021 | $2,347 | 160 | AbbVie Inc. ($489.29) |
| 2020 | $1,298 | 91 | Allergan, Inc. ($188.50) |
| 2019 | $868.47 | 49 | Boehringer Ingelheim Pharmaceuticals, Inc. ($182.85) |
| 2018 | $1,034 | 55 | Novo Nordisk Inc ($422.71) |
| 2017 | $797.92 | 62 | SANOFI-AVENTIS U.S. LLC ($170.01) |
All Payment Transactions
720 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $4.40 | General |
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Obesity | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.03 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Biological | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,386 | 4,096 | $340,371 | $163,494 |
| 2022 | 20 | 1,940 | 3,011 | $258,062 | $126,807 |
| 2021 | 20 | 1,658 | 2,502 | $221,633 | $111,291 |
| 2020 | 24 | 1,750 | 2,638 | $253,896 | $110,608 |
Total Patients
7,734
Total Services
12,247
Medicare Billing
$512,198
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 873 | $144,045 | $70,678 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 217 | 217 | $39,060 | $26,551 | 68.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 220 | 220 | $30,360 | $16,997 | 56.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 96 | 96 | $11,520 | $7,278 | 63.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 55 | $12,870 | $6,118 | 47.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 247 | 482 | $10,122 | $4,968 | 49.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 95 | 139 | $18,765 | $4,708 | 25.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 97 | 275 | $13,200 | $4,363 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 248 | 500 | $6,000 | $4,183 | 69.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 216 | 216 | $15,552 | $3,728 | 24.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 115 | $5,750 | $3,292 | 57.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 149 | 171 | $5,643 | $2,217 | 39.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 203 | $6,090 | $1,943 | 31.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 102 | 184 | $6,072 | $1,742 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $3,000 | $1,196 | 39.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 22 | 57 | $3,078 | $898.30 | 29.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 19 | 19 | $986.00 | $634.45 | 64.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 43 | 63 | $2,835 | $566.10 | 20.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $950.00 | $543.97 | 57.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 12 | $990.00 | $321.21 | 32.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 75 | 136 | $2,856 | $299.20 | 10.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 12 | 19 | $627.00 | $266.95 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 637 | $105,105 | $54,951 | 52.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $28,440 | $19,259 | 67.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 165 | 165 | $22,770 | $12,781 | 56.1% |
About Dr. Stephen Wright, MD
Dr. Stephen Wright, MD is a Family Medicine healthcare provider based in Lapel, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235143439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Wright, MD has received a total of $12,366 in payments from pharmaceutical and medical device companies, with $1,710 received in 2024. These payments were reported across 720 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($12,143).
As a Medicare-enrolled provider, Wright has provided services to 7,734 Medicare beneficiaries, totaling 12,247 services with total Medicare billing of $512,198. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lapel, IN
- Active Since 07/27/2006
- Last Updated 03/07/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235143439
Products in Payments
- VRAYLAR (Drug) $794.08
- Kerendia (Drug) $718.83
- Ozempic (Drug) $647.44
- JARDIANCE (Drug) $603.16
- TRELEGY ELLIPTA (Drug) $539.46
- ELIQUIS (Drug) $423.34
- BREZTRI (Drug) $417.55
- Otezla (Drug) $283.46
- XIFAXAN (Drug) $255.97
- PREVNAR 20 (Biological) $255.77
- Wegovy (Drug) $255.24
- Rybelsus (Drug) $247.67
- UBRELVY (Drug) $237.63
- ENTRESTO (Drug) $235.87
- LO LOESTRIN FE (Drug) $230.52
- EMGALITY (Drug) $223.92
- Saxenda (Drug) $220.58
- ANNOVERA (Drug) $211.68
- MYRBETRIQ (Drug) $201.50
- INTELLIS ADAPTIVESTIM (Device) $183.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.